Ignite Creation Date:
2024-05-06 @ 4:22 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04965766
Status:
RECRUITING
Last Update Posted:
2023-05-18
First Post:
2021-06-03
Brief Title:
Patritumab Deruxtecan U3-1402 in Unresectable Locally Advanced or Metastatic Breast Cancer
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-03
First Submit QC Date:
July 7 2021
Study First Post Date:
2021-07-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-16
Last Update Post Date:
2023-05-18
Last Update Post Date Type:
ACTUAL